Latest News

 Filter by Provider

SoundHound AI is trading flat Friday morning, stabilizing after a volatile post-earnings session on Thursday.

Lucid Group, Tesla, and Rivian are all attempting bold transformations.

Gold appears poised to break out of its current consolidation, as the recent dollar rally has left prices subdued.

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 billion, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 15.6% above analysts’ consensus estimates.

Luxury furniture retailer Arhaus (NASDAQ:ARHS) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 8% year on year to $344.6 million. Guidance for next quarter’s revenue was optimistic at $351 million at the midpoint, 2% above analysts’ estimates. Its GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.

Taiwan Semiconductor raised prices for advanced chips under 5nm to offset higher costs. Apple may increase iPhone 18 prices.

Amazon just crushed Q3 earnings -- but the real story lies in its AI-fueled AWS growth. Here's why I believe this could be the start of Amazon's next big rally.

FDA adds six drugs to its priority voucher program as CMS and the White House unveil measures to speed reviews and lower prescription costs.

Unity Software Inc's Q3 results showed double-digit sequential growth, driven by its Vector platform's machine learning improvements and new data integrations.

Advanced Micro Devices recently reported earnings, but investors should keep a closer eye on its 2025 Financial Analyst Day scheduled on Nov. 11.

Restaurant company Texas Roadhouse (NASDAQ:TXRH) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.8% year on year to $1.44 billion. Its GAAP profit of $1.25 per share was 2.9% below analysts’ consensus estimates.

Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 31.4% year on year to $209.4 million. The company’s full-year revenue guidance of $780 million at the midpoint came in 3.8% above analysts’ estimates. Its non-GAAP profit of $2.25 per share was 21% above analysts’ consensus estimates.

Hair care company Olaplex (NASDAQ:OLPX) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 3.8% year on year to $114.6 million. The company expects the full year’s revenue to be around $420.5 million, close to analysts’ estimates. Its GAAP profit of $0.02 per share was $0.02 above analysts’ consensus estimates.

Buy now, pay later company Affirm (NASDAQ:AFRM) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 33.6% year on year to $933.3 million. Its GAAP profit of $0.23 per share was significantly above analysts’ consensus estimates.

Constellation Energy reported Q3 revenue of $6.57 billion, topping estimates, while EPS of $3.04 came in slightly below expectations as the company narrowed its full-year guidance.

Navitas is expecting a transition year in 2026 as it prepares for strong growth in 2027.

Blood products company Haemonetics (NYSE:HAE). announced better-than-expected revenue in Q3 CY2025, but sales fell by 5.3% year on year to $327.3 million. Its non-GAAP profit of $1.27 per share was 14.3% above analysts’ consensus estimates.

You'll need to delay claiming benefits and meet income requirements to be eligible for the maximum benefit.

For investors with a high risk tolerance, Upstart stock offers significant upside.

AMC Networks reported mixed Q3 2025 results with revenue decline of 6.3%, beating analyst estimate. Streaming revenue grew and will be largest source this year.

Eyewear retailer Warby Parker (NYSE:WRBY) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 15.2% year on year to $221.7 million. The company’s full-year revenue guidance of $872.5 million at the midpoint came in 1.5% below analysts’ estimates. Its GAAP profit of $0.05 per share was in line with analysts’ consensus estimates.

Health insurance company Oscar Health (NYSE:OSCR) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 23.2% year on year to $2.99 billion. On the other hand, the company’s full-year revenue guidance of $12.1 billion at the midpoint came in 0.5% above analysts’ estimates. Its GAAP loss of $0.53 per share was 6.8% below analysts’ consensus estimates.

Online new and used car marketplace Cars.com (NYSE:CARS) met Wall Streets revenue expectations in Q3 CY2025, with sales up 1.1% year on year to $181.6 million. Its non-GAAP profit of $0.48 per share was in line with analysts’ consensus estimates.

Higher education company Strategic Education (NASDAQ:STRA) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 4.6% year on year to $319.9 million. Its non-GAAP profit of $1.64 per share was 25.8% above analysts’ consensus estimates.

Heating and cooling solutions company AAON (NASDAQ:AAON) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 17.4% year on year to $384.2 million. Its non-GAAP profit of $0.37 per share was 14.9% above analysts’ consensus estimates.